Phathom Pharmaceuticals, Inc. PHAT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s current ratio?
- Phathom Pharmaceuticals, Inc. (PHAT) reported current ratio of 2.2× in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s current ratio decreased by 38.2% year-over-year, from 3.6× to 2.2×.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s current ratio has grown at a -19.9% compound annual growth rate (CAGR), from 5.2× to 1.7×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.